RecruitingNot ApplicableNCT05793801

Study of the Impact of Frequency of Changing PICCline Dressings in Patients With Acute Leukemia


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

60 participants

Start Date

Jun 6, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Peripherally Inserted Central Catheters have been widely used for many years for the administration of chemotherapy to patients with cancer. However, its use entails significant infectious complications and high risks of death.The hypothesis is that increasing the rate of PICCline dressing changes will reduce the occurrence of catheter-related infections.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Patient with a diagnosis of acute myeloblastic leukemia.
  • Patient going on intensive induction chemotherapy (causing a "high risk" situation of severe infection defined as profound neutropenia ( Polymorphonuclear neutrophil count \<500/mm3) and lasting (\>7 days).
  • Patients who have had a PICCline placed within the last 24 hours or who require a PICCline placement as part of their hospitalization under optimal hygiene and asepsis conditions.
  • Patient housed in a protected environment (flow chamber or Plasmair®).
  • Patient who has given free and informed consent.
  • Patient affiliated or beneficiary of a health insurance plan.
  • Adult patient (≥18 years old).

Exclusion Criteria5

  • Patient with PICCline placed during a previous hospitalization.
  • Patient in an exclusion period determined by another study.
  • Patient under court protection, guardianship or curatorship.
  • Patient unable to give consent.
  • Patient for whom it is impossible to give informed information.

Interventions

OTHERDressing change

The patient circuit corresponds to that of usual care. Not part of usual patient management: * The rhythm of PICCline dressing changes, which differed between the two groups. * The collection of pain on a visual analog scale at each dressing change.


Locations(1)

CHU de Montpellier Hôpital St-Eloi

Montpellier, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05793801


Related Trials